Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar.

Similar presentations


Presentation on theme: "Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar."— Presentation transcript:

1 Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar Carcinoma): Exploratory Analysis of the IFCT-0401 Trial  Michaël Duruisseaux, MD, Laurence Baudrin, MBsc, Elisabeth Quoix, MD, PhD, Marie Wislez, MD, PhD, Denis Moro-Sibilot, MD, PhD, Daniel Coëtmeur, MD, Isabelle Monnet, MD, Pierre Mourlanette, MD, Jean-François Morère, MD, PhD, Jean-Charles Soria, MD, PhD, Virginie Westeel, MD, PhD, Franck Morin, MBsc, Jacques Cadranel, MD, PhD  Journal of Thoracic Oncology  Volume 7, Issue 9, Pages (September 2012) DOI: /JTO.0b013e31825ab897 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Curve for progression-free survival using gemcitabine-based chemotherapy (black line) or taxane-based chemotherapy (green line) as second-line treatment. CI, confidence interval. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e31825ab897) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Waterfall plot of progression-free survival in second-line therapy (A) and third-line therapy (B) for each patient according to the third-generation chemotherapy regimens used. Median progression-free survival in months and its extent according to each third-generation chemotherapy regimen is shown in the insert box. Patients who discontinued treatment because of toxicity are marked with an asterisk. PFS, progression-free survival. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e31825ab897) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 3 Waterfall plot of progression-free survival using second-line or third-line therapies for each patient according to histological subtypes. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e31825ab897) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar."

Similar presentations


Ads by Google